Nextleaf To Launch THC-O As An Excise Tax-Free Alternative To Delta-9-THC

Nextleaf Solutions Ltd. OILFF OILS L provided an update on its specialty molecules division, specifically the company's patented novel route of manufacturing D9-tetrahydrocannabinol acetate, colloquially referred to as THC-O.

Nextleaf has recently produced THC-O under the company's Health Canada research license in anticipation of commercialization. Nextleaf has validated its manufacturing process of THC-O through third-party analytical testing.

The company is of the understanding that THC-O is not subject to excise tax as it does not meet the definition of "Total THC" as defined under the Excise Act 2001, which is aligned with the definition of the same in the Cannabis Act.

In Canada, excise tax of a regulated cannabis extract is based on the amount of total delta-9-THC present. Excise tax is a critical issue in the industry, with some cannabis products manufactured with delta-9-THC subject to excise tax over 40% of the duty paid landed cost to provincial government distributors and medical cannabis distributors.

With THC-O, Nextleaf sees potential for market disruption by marketing its novel cannabinoid ingredient as an excise tax-free alternative to delta-9-THC. Nextleaf intends to commercialize the ingredient as a therapeutic product distributed to provincial distributors and medical cannabis sales partners under the company's Health Canada cannabis licenses.

Anecdotally, THC-O products have a more gradual onset, are longer-lasting, and have psychedelic-like effects, as compared to delta-9-THC.

Nextleaf's patented process to manufacture THC-O enables the standardization of a more potent analog of THC. The company holds U.S. and Canadian patents, along with a U.S. patent for a less efficient method to produce THC-O.

Photo by Diyahna Lewis on Unsplash

Related News

Nextleaf Q2 2022 Revenue Grows 774% YoY, Reports Management Changes

Nextleaf Granted U.S. Patent For Technology That Maximizes Cannabinoid Yield & Reduces Waste

Nextleaf Solutions Touts Positive Trends In Gross Margin, Posts $1.15M In Q1 Revenue

Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...